Description

The Childhood Cancer Therapeutic Catalyst is funded by Cancer Research UK to accelerate the translation of discovery research into novel therapeutics for children and young people with cancer. It supports early drug discovery across all childhood cancer indications and modalities, de-risking promising projects so they can progress toward further research, funding or partnering.

Projects run collaboratively between academic laboratories and the Therapeutic Innovation team at Cancer Research Horizons. Supported work includes validation of novel targets and pathways, new therapeutic approaches to validated targets, target identification through platforms, assays and screens, and drug discovery feasibility studies. The emphasis is on high-impact discoveries with a clear route to patient benefit, validation of the project hypothesis and positioning for onward investment.